Emmaus Life Sciences (EMMA) Notes Payables (2010 - 2026)
Emmaus Life Sciences (EMMA) recorded Notes Payables of $17.33 million in Q2 2026, up 3.1% from $16.8 million a year earlier but down 0.1% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Notes Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences reported Notes Payables of $17.38 million, up 2.2% from FY2024.
- Annual Notes Payables has increased for four straight years, with a five-year compound annual growth rate of 164.6% (FY2020 to FY2025).
- Across earlier years, Notes Payables came in at $17.01 million in FY2024 (+3.9%), $16.38 million in FY2023 (+11.8%), $14.66 million in FY2022 (+44.3%) and $10.16 million in FY2021.
- Quarterly Notes Payables has ranged from $400,000 in Q3 2021 to $17.38 million in Q4 2025 over the past five years.
- On a year-over-year basis, Notes Payables has increased for seven consecutive quarters, with growth averaging 2.2% over the last eight quarters.
- Peak year-over-year performance for Notes Payables in the last five years was growth of 44.3% in Q4 2022, against a decline of 51.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.36 million (Q1 2026), $17.38 million (Q4 2025) and $16.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.33 Mn |
| Mar 31, 2026 | 17.36 Mn |
| Dec 31, 2025 | 17.38 Mn |
| Sep 30, 2025 | 16.80 Mn |
| Jun 30, 2025 | 16.80 Mn |
| Mar 31, 2025 | 16.86 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 16.21 Mn |
| Jun 30, 2024 | 16.33 Mn |
| Mar 31, 2024 | 16.59 Mn |
| Dec 31, 2023 | 16.38 Mn |
| Sep 30, 2023 | 16.72 Mn |
| Jun 30, 2023 | 14.31 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Dec 31, 2022 | 14.66 Mn |
| Sep 30, 2022 | 14.35 Mn |
| Jun 30, 2022 | 14.06 Mn |
| Mar 31, 2022 | 10.57 Mn |
| Dec 31, 2021 | 10.16 Mn |
| Sep 30, 2021 | 400,000.00 |
API Access
Emmaus Life Sciences Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();